The Patent Finder

Miravant Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Miravant Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Miravant Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,521,551Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
Formerly held
Lapsed on the fee record
Ended Apr 21, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 21, 2021USPTO record
US 6,462,192Processes for large scale production of tetrapyrroles
Formerly held
Term ended
Term ended Apr 5, 2021 · USPTO record
Term endedTerm ended Apr 5, 2021USPTO record
US 6,605,606Solid forms of tin ethyl etiopurpurin and processes for producing such forms
Formerly held
Term ended
Term ended Aug 4, 2020 · USPTO record
Term endedTerm ended Aug 4, 2020USPTO record
US 6,794,505Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
Formerly held
Term ended
Term ended Mar 30, 2020 · USPTO record
Term endedTerm ended Mar 30, 2020USPTO record
US 6,054,449Compounds and method for PDT of intimal hyperplasia and other diseases
Formerly held
Lapsed on the fee record
Ended Apr 25, 2012 · USPTO record
Lapsed on the fee recordEnded Apr 25, 2012USPTO record
US 6,444,194Indium photosensitizers for PDT
Lapsed on the fee record
Ended Sep 3, 2010 · USPTO record
Lapsed on the fee recordEnded Sep 3, 2010USPTO record
US 6,906,050Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis
Lapsed on the fee record
Ended Jun 14, 2009 · USPTO record
Lapsed on the fee recordEnded Jun 14, 2009USPTO record
US 6,827,926Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
Lapsed on the fee record
Ended Dec 7, 2008 · USPTO record
Lapsed on the fee recordEnded Dec 7, 2008USPTO record
US 6,376,483Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
Lapsed on the fee record
Ended Apr 23, 2006 · USPTO record
Lapsed on the fee recordEnded Apr 23, 2006USPTO record
US 5,973,141Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides
Term ended
Term ended no later than Oct 26, 2019 · Low confidence
Term endedTerm ended no later than Oct 26, 2019Low confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited